APA (7th ed.) Citation

Karadeniz, Y., & Karakose, M. (2025). Non-Invasive Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Risk in Acromegaly Indicates Persistence of Cardiac Risks Despite Biochemical Disease Control. Journal of Clinical Medicine, 14(14), 4822. https://doi.org/10.3390/jcm14144822

Chicago Style (17th ed.) Citation

Karadeniz, Yusuf, and Melia Karakose. "Non-Invasive Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Risk in Acromegaly Indicates Persistence of Cardiac Risks Despite Biochemical Disease Control." Journal of Clinical Medicine 14, no. 14 (2025): 4822. https://doi.org/10.3390/jcm14144822.

MLA (9th ed.) Citation

Karadeniz, Yusuf, and Melia Karakose. "Non-Invasive Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Risk in Acromegaly Indicates Persistence of Cardiac Risks Despite Biochemical Disease Control." Journal of Clinical Medicine, vol. 14, no. 14, 2025, p. 4822, https://doi.org/10.3390/jcm14144822.